Login     Register  
    Home  |   Your Profile  |   Search  |   About Us  |   Disclaimer  |   Pricing  |   Participating on CanBiotech
Can Biotech - BioPharma Portal and B2B Marketplace Fifth Annual Portfolio Management/Eighth Annual Strategic Resource Management
Site Search:
    Home Outsourcing Asia Outsourcing Showcase RFQ/Showcase-Subscribe BioChannels Research Store Investor/Venture Capital Directory Events News Career Industry Publications Tools & Resources CanBiotech Outsourcing
Analytical 
Animal Services 
Antibody and Antigen Services 
Basic Research 
Bioinformatics 
Cell/Tissue Culture 
Chemistry 
Clinical Research Organizations 
Compliance 
Contract Research Organizations 
Data Analysis and Management 
Drug Development 
Genomics 
Health and Safety 
Information Technology 
Manufacturing 
Packaging 
Peptide/Protein Services 
Process Development 
Proteomics 
Product Marketing 
Purification 
Quality Assurance and Control 
Regulatory 
Sequencing 
Synthesis 
Validation and Studies 

Academic/Research 
Biotechnology 
Bioinformatics 
Pharmaceutical 
Healthcare 
Government 
Non-Profit 
Services 
Startups 
Incubators 
Centers/Parks 
Technology Transfer Offices 
 Add Company 


Services : Research Services
ENDPOINTGo Back  


Address:
7470 NE Manual Road
Bainbridge Island, WA 98110
UNITED STATES
Map It

Contact Info:
T: (206) 780-2905
F: (206) 780-2907


Website URL:
www.primaryendpoint.com/



To send a request for quote to this organization please click the button below



Organization:
ENDPOINT

About Us
Endpoint (formerly International Drug Development Consulting) provides clients with high-quality, authoritative advice on the clinical development of medicines.

Endpoint's clients include multinational pharmaceutical companies, emerging biomedical companies, biotechnology investment firms, contract research organizations, regulatory agencies, and national health services.

The company was founded by Kenneth Klein, MD, a Harvard-trained physician board-certified in both internal medicine and gastroenterology. He has over 15 years experience in the pharmaceutical industry in both the US and Europe.

Ken's special interests include interpreting complex preclinical and clinical data, developing novel designs for pivotal clinical trials, and helping biomedical companies plan comprehensive development strategies early in the life cycle of their products. Endpoint has offices in Seattle and London.


Other Categories this company can be located in
Drug Development

Participating on CanBiotech's Networks
Using the Site Privacy & Security Statement

Service Provider Spotlight/Showcase Guide
Advertise with us Directory Guide & Access Policy
News Postings Event Postings CanBiotech Newsletters

© 2000-2010 CanBiotech™ Inc.